Murofushi Yoshiteru 室伏善照

… Alternative Names

MUROFUSHI Yoshiteru 室伏善照

室伏善照ムロフシヨシテル

Less

Researcher Number	50448578
Other IDs
Affiliation (Current)	2025: 名古屋大学, 医学系研究科, 研究員
Affiliation (based on the past Project Information) *help	2016: 京都大学, 医学研究科, 特定助教 2015: 京都大学, 医学研究科, 研究員 2013 – 2015: 京都大学, 医学(系)研究科(研究院), 研究員 2007: 鹿児島大学, 大学院・医歯学総合研究科, 助教
Review Section/Research Field	Principal Investigator Experimental pathology / Urology Except Principal Investigator Urology / Pediatrics
Keywords	Principal Investigator 褐色細胞腫 / VHL / がん抑制遺伝子 / 遺伝性疾患 / 腫瘍学 / エピジェネティクス / 腎細胞癌 Except Principal Investigator Prostate cancer / Androgen / CRPC … More / バイオテクノロジー / トランスレーショナルリサーチ / 癌 / ウイルス / 遺伝子 Less

Novel disease model of human inherited cancer syndromes using patient-derived iPS cellsPrincipal Investigator
- Principal Investigator
  
  Murofushi Yoshiteru
- Project Period (FY)
  2015 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Experimental pathology
- Research Institution
  Kyoto University
Identification of new therapiutic molecules for CRPC by using library screening methods
- Principal Investigator
  
  Nakamura Eijiro
- Project Period (FY)
  2014 – 2015
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Urology
- Research Institution
  Kyoto University
Screening for novel therapeutic target molecule focused on the aberrant epigenetic gene regulation in renal cell carcinoma.Principal Investigator
- Principal Investigator
  
  MUROFUSHI Yoshiteru
- Project Period (FY)
  2013 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Urology
- Research Institution
  Kyoto University
Development of innovative gene therapy of conditionally regulating adenovirus for treating pediatric solid cancer
- Principal Investigator
  
  KOSAI Kenichirou
- Project Period (FY)
  2007 – 2009
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Pediatrics
- Research Institution
  Kagoshima University

All 2016 2015 2014 2009 2008 2007 Other

All Journal Article Presentation

[Journal Article] iPS細胞による癌研究 -遺伝性腫瘍疾患のモデル化と創薬研究-2016
- Author(s)
  室伏善照，木我敬太，杉山愛子, 日高裕輔, 宮脇良文, 中村英二郎
- Journal Title
  
  実験医学
  
  Volume: 34 Pages: 546-550
- Data Source
  KAKENHI-PROJECT-15K21111
[Journal Article] iPS細胞による癌研究 -遺伝性腫瘍疾患のモデル化と創薬研究-.2016
- Author(s)
  室伏善照，木我敬太，杉山愛子, 日高裕輔, 宮脇良文, 中村英二郎.
- Journal Title
  
  実験医学
  
  Volume: 34 (4) Pages: 546-550
- Data Source
  KAKENHI-PROJECT-15K21111
[Journal Article] Phenotypic characteristics of renal disease in patients with von Hippel-Lindau disease.2014
- Author(s)
  室伏善照, 木我敬太, 中村英二郎
- Journal Title
  
  腎と透析
  
  Volume: 77 Pages: 770-773
- Data Source
  KAKENHI-PROJECT-25870348
[Journal Article] Efficacy of autologous fat injection laryngoplasty with an adenoviral vector expressing hepatocyte growth factor in a canine model2009
- Author(s)
  Umeno H, Chitose S, Murofushi Y, Kosai K, Sato K, Kawahara A, Nakashima T.
- Journal Title
  
  The Journal of laryngology and otology 31
  
  Pages: 24-29
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19390286
[Journal Article] 革新的癌治療薬となる遺伝子・ウイルス治療薬と肝疾患への再生医薬.2009
- Author(s)
  室伏善照, 小戝健一郎
- Journal Title
  
  ケミカルエンジニヤリング 54(1)
  
  Pages: 32-38
- Data Source
  KAKENHI-PROJECT-19390286
[Presentation] Development of novel therapeutic strategy based on cancer genomics by using patient-derived iPS cells.2015
- Author(s)
  Nakamura E, Murofushi Y, Kiga K, Imamura K, Sugiyama A, Kinoshita K, Osawa M, Niwa A, Saito M, Shibasaki N, Kamba T, Inoue H, Ogawa O.
- Organizer
  第74回日本癌学会学術集会
- Place of Presentation
  名古屋
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-15K21111
[Presentation] 患者由来iPS細胞を用いた遺伝性腫瘍症候群VHL病の新規病態モデルの創成.2015
- Author(s)
  室伏善照.
- Organizer
  再生医療実用化研究事業・再生医療実現拠点ネットワークプログラム合同シンポジウム科学者達による挑戦 iPS細胞を用いた疾患・創薬研究
- Place of Presentation
  東京
- Year and Date
  2015-12-14
- Data Source
  KAKENHI-PROJECT-15K21111
[Presentation] Conditionally replicating adenovirus regulated with 4 independent caneer-specific factors enhances cancer-specificity without reducing potentanti-cancer effect ; the importance of EIB promoter.2008
- Author(s)
  Murofushi Y, Nagano S, Komiya S, Kosai K.
- Organizer
  The American Society of Gene Therapy's 11th Annual Meeting
- Place of Presentation
  Boston, USA
- Data Source
  KAKENHI-PROJECT-19390286
[Presentation] Conditionally replicating adenovirus regulated with 4 independent cancer-specific factors enhances cancer-specificity without reducing potent anti-cancer effect ; the importance of E1B promoter.2008
- Author(s)
  室伏善照, 小戝健一郎, et al
- Organizer
  The American Society of Gene Therapy's 11th Annual Meeting
- Place of Presentation
  Boston, USA
- Data Source
  KAKENHI-PROJECT-19390286
[Presentation] Conditionally Replicating Adenovirus Regulated by Survivin and CEA Promoters Exerted More Strict Cancer Specificity and Potent Anti-Cancer Effect.2007
- Author(s)
  Yoshiteru Murofushi, Junichi Kamizono, Ngin Cin Khai, Tomoyuki Takahashi, Setsuro Komiya, Ken-ichiro Kosai.
- Organizer
  第13回日本遺伝子治療学会
- Place of Presentation
  名古屋市(愛知がんセンター)
- Data Source
  KAKENHI-PROJECT-19390286
[Presentation] 独立2〜6因子で癌を標的化・治療する癌特異的増殖制御型アデノウイルス.2007
- Author(s)
  小戝健一郎, 室伏善照.
- Organizer
  第66回日本癌学会学術集会
- Place of Presentation
  横浜市(パシフィコ横浜)
- Year and Date
  2007-10-04
- Data Source
  KAKENHI-PROJECT-19390286
[Presentation] Survivin-Responsive Conditionally Replicating Adenovirus Additionally Regulated with Cancer Specificity without Reducing Anti-Cancer Effect.2007
- Author(s)
  室伏善照, 小戝健一郎, et al.
- Organizer
  The 10th Annual Meeting of the American Society of Gene Therapy
- Place of Presentation
  Seattle, Washington, USA(国際・一般演題)
- Data Source
  KAKENHI-PROJECT-19390286
[Presentation] Survivin-Responsive Conditionally Replicating Adenovirus Additionally Regulated with Cancer Specificity without Reducing Anti-Cabcer Effect.2007
- Author(s)
  Yoshiteru Murofushi, Junichi Kamizono, Ngin Cin Khai, Tomoyuki Takahashi, Setsuro Komiya, Ken-ichiro Kosai.
- Organizer
  The 10th Annual Meeting of the American Society of Gene Therapy
- Place of Presentation
  Seattle, Washington, USA
- Year and Date
  2007-06-01
- Data Source
  KAKENHI-PROJECT-19390286
[Presentation] Survivin/CEA-responsive conditionally replicating adenovirus enhances cancer specificity with potent anti-cancer effect.2007
- Author(s)
  室伏善照, 神囿純一, 小戝健一郎.
- Organizer
  第66回日本癌学会学術集会
- Place of Presentation
  横浜市(パシフィコ横浜)
- Year and Date
  2007-10-04
- Data Source
  KAKENHI-PROJECT-19390286
[Presentation] Conditionally Replicating Adenovirus Regulated by Survivin and CEA Promoters Exerted More Strict Cancer Specificity and Potent Anti-Cancer Effect.2007
- Author(s)
  室伏善照, 小戝健一郎, et al.
- Organizer
  第13回日本遺伝子治療学会
- Place of Presentation
  愛知(国内・一般演題)
- Data Source
  KAKENHI-PROJECT-19390286
[Presentation] Survivin/CEA-responsive conditionally replicating adenovirus enhances cancer specificity with potent anti-cancer effect.2007
- Author(s)
  室伏善照, 小戝健一郎, 等
- Organizer
  第66回日本癌学会学術集会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-19390286
[Presentation] 独立2～6因子で癌を標的化・治療する癌特異的増殖制御型アデノウイルス2007
- Author(s)
  小戝健一郎, 室伏善照
- Organizer
  第66回日本癌学会学術集会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-19390286
[Presentation] Development of new experiment models for VHL hereditary cancer disease by using patient-derived iPS cells.
- Author(s)
  Murofushi Y, Imamura K, Niwa A, Yamasaki T, Kamba T, Saito M, Inoue H, Ogawa O and Nakamura E
- Organizer
  11th Internationl VHL Medical Symposium 2014
- Place of Presentation
  Madrid, Spain
- Year and Date
  2014-10-23 – 2014-10-25
- Data Source
  KAKENHI-PROJECT-25870348
[Presentation] Novel disease model of pheochromocytoma using VHL patient-derived iPS cells.
- Author(s)
  Murofushi Y, Imamura K, Kiga K, Sugiyama A, Inoue H, Ogawa O, Hiai H and Nakamura E
- Organizer
  The 4th Global Cancer Genomics Consortium Symposium
- Place of Presentation
  京都
- Year and Date
  2014-11-14 – 2014-11-15
- Data Source
  KAKENHI-PROJECT-25870348
[Presentation] Development of new therapeutic strategy for VHL hereditary cancer disease by using patient-derived iPS cells.
- Author(s)
  中村英二郎, 室伏善照, 今村恵子, 丹羽明, 杉山愛子, 木下和生, 新垣隆一郎, 柴崎昇, 山崎俊成, 神波大己, 斎藤潤, 井上治久, 小川修
- Organizer
  第73 回日本癌学会学術集会
- Place of Presentation
  横浜
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-25870348

1. KOSAI Kenichirou (90258418)

# of Collaborated Projects: 1 results

# of Collaborated Products: 12 results
2. Nakamura Eijiro (90293878)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. INOUE TAKAHIRO (80511881)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 小宮節郎 (30178371)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
5. 河野嘉文 (20260680)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 高橋知之 (20332687)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 前薗理恵 (90381178)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 高橋和之

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results

Murofushi Yoshiteru 室伏 善照

MUROFUSHI Yoshiteru 室伏 善照

室伏 善照 ムロフシ ヨシテル

Research Projects

Research Products

Co-Researchers

Novel disease model of human inherited cancer syndromes using patient-derived iPS cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Identification of new therapiutic molecules for CRPC by using library screening methods

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Screening for novel therapeutic target molecule focused on the aberrant epigenetic gene regulation in renal cell carcinoma.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of innovative gene therapy of conditionally regulating adenovirus for treating pediatric solid cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] iPS細胞による癌研究 -遺伝性腫瘍疾患のモデル化と創薬研究-2016

Author(s)

Journal Title

Data Source

[Journal Article] iPS細胞による癌研究 -遺伝性腫瘍疾患のモデル化と創薬研究-.2016

Author(s)

Journal Title

Data Source

[Journal Article] Phenotypic characteristics of renal disease in patients with von Hippel-Lindau disease.2014

Author(s)

Journal Title

Data Source

[Journal Article] Efficacy of autologous fat injection laryngoplasty with an adenoviral vector expressing hepatocyte growth factor in a canine model2009

Author(s)

Journal Title

Data Source

[Journal Article] 革新的癌治療薬となる遺伝子・ウイルス治療薬と肝疾患への再生医薬.2009

Author(s)

Journal Title

Data Source

[Presentation] Development of novel therapeutic strategy based on cancer genomics by using patient-derived iPS cells.2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 患者由来iPS細胞を用いた遺伝性腫瘍症候群VHL病の新規病態モデルの創成.2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Conditionally replicating adenovirus regulated with 4 independent caneer-specific factors enhances cancer-specificity without reducing potentanti-cancer effect ; the importance of EIB promoter.2008

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] Conditionally replicating adenovirus regulated with 4 independent cancer-specific factors enhances cancer-specificity without reducing potent anti-cancer effect ; the importance of E1B promoter.2008

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] Conditionally Replicating Adenovirus Regulated by Survivin and CEA Promoters Exerted More Strict Cancer Specificity and Potent Anti-Cancer Effect.2007

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] 独立2〜6因子で癌を標的化・治療する癌特異的増殖制御型アデノウイルス.2007

Author(s)

Organizer

Murofushi Yoshiteru 室伏善照

MUROFUSHI Yoshiteru 室伏善照

室伏善照ムロフシヨシテル